IGI INC
8-K, 1999-05-05
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CALCASIEU REAL ESTATE & OIL CO INC, 10-Q, 1999-05-05
Next: OMNICARE INC, 424B3, 1999-05-05



                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934


Date of Report (Date of Earliest Event Reported): May 3, 1999


                                    IGI, Inc.
             (Exact Name of Registrant as Specified in its Charter)


                                    Delaware
                 (State or Other Jurisdiction of Incorporation)


       001-08568                                         01-0355758
(Commission File Number)                    (I.R.S. Employer Identification No.)



Wheat Road and Lincoln Avenue
Buena, New Jersey                                           08310   
(Address of Principal Executive Offices)                 (Zip Code)


                                 (609) 697-1441
              (Registrant's Telephone Number, Including Area Code)

                                 Not Applicable
          (Former Name or Former Address, if Changed Since Last Report)




<PAGE>



Item 5.  Other Events.

     On May 3, 1999, IGI, Inc. (the "Company") announced that on April 14, 1999,
a lawsuit was filed in the U.S.  District Court for the Southern District of New
York by Cohanzick  Partners,  LP, against the Company and certain of its present
and former  directors,  officers  and  employees.  The suit seeks  approximately
$420,000 in damages and alleges  violations of the  securities  laws,  fraud and
negligent  misrepresentation  concerning  certain  disclosures  made  and  other
actions taken by the Company in 1996 and 1997.

     The foregoing  description of the announcement is qualified in its entirety
by reference to the full text of the  Company's  press release which is filed as
Exhibit  99 to this  Current  Report  on Form  8-K and  incorporated  herein  by
reference.

Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

     (a) Financial Statements of Businesses Acquired.

     Not applicable.

     (b) Pro Forma Financial Information.

     Not applicable.

     (c) Exhibits.

     The  exhibit  following  the  Exhibit  Index  is  incorporated   herein  by
     reference.





                                       -2-

<PAGE>



                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date: May 5, 1999                                     IGI, INC.   
                                               -------------------------
                                                    (Registrant)



                                      By:      /s/ Edward B. Hager, M.D.
                                               -------------------------
                                               Edward B. Hager, M.D.
                                               Chairman of the Board and
                                               Chief Executive Officer




                                       -3-

<PAGE>



                                  EXHIBIT INDEX


Exhibit
Number                                      Description
- ------                                      -----------

 99                                Press Release dated May 3, 1999.






                                                                      Exhibit 99

News From:

IGI

Buena, NJ 08310

================================================================================
Release Date:                                Contact:
                       May 3, 1999                            Thomas Redington
                                                              (203) 222-7399


                IGI ANNOUNCES LITIGATION WITH FORMER SHAREHOLDER


Buena,  NJ May 3, 1999.  IGI, Inc.,  (AMEX:IG) today announced that on April 14,
1999, a lawsuit was filed in the U.S.  District Court for the Southern  District
of New York by Cohanzick  Partners,  LP,  against IGI,  Inc., and certain of its
present and former  directors,  officers and  employees.  The suit,  which seeks
approximately $420,000 in actual damages together with fees, costs and interest,
alleges violations of the securities laws, fraud and negligent misrepresentation
concerning  certain  disclosures  made and other actions taken by the company in
1996 and 1997.

The Company  believes that the plaintiff's  allegations are factually  incorrect
and legally inadequate and will defend the lawsuit vigorously. While the lawsuit
is at a very  preliminary  stage and no discovery  has taken place,  the Company
believes  that an  unfavorable  outcome  in the suit  would not have a  material
adverse  impact  upon  the  Company's  financial  condition,  although  it could
negatively  affect the results of operations  for the period in which the matter
is resolved.

The new IGI is a company that is committed to grow by applying its  technologies
to deliver cost effective solutions to customer problems. IGI solves problems in
consumer and skin care markets,  petcare and poultry  production.  An increasing
number   of   IGI's   solutions   are   based   on  the   patented   Novasome(R)
microencapsulation technology. Licensed from a former subsidiary, the technology
offers  value-added  qualities  to  cosmetics,  skin  car  products,  chemicals,
biocides,  pesticides,  fuels, vaccines,  medicines,  foods, beverages,  petcare
products and other products.

This  report  contains  forward-looking  statements  relating to IGI's hopes and
expectations for the future. For this purpose,  any statements  contained herein
that are not statements of historical  fact may be deemed to be  forward-looking
statements.   Without  limiting  the  foregoing,  words  and  phrases  such  as,
"believes",  "anticipates", "plans", "expects", "are confident that" and similar
expressions are intended to identify forward looking-statements. Such statements
involve a number of risks and  uncertainties.  Among the important  factors that
could cause  actual  results  differ  materially  from those  indicated  by such
forward-looking   statements  are,  competitive   pressures,   general  economic
conditions,  and the  risk  factors  detailed  in  IGI's  periodic  reports  and
registration statements filed with the Securities and Exchange Commission.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission